NCT03221426 2026-03-09
KEYNOTE-585
Merck Sharp & Dohme LLC
Phase 3 Completed
Clinical Trials
87 trialsNCT07437573 2026-02-27
KLASS-09
Korea University Guro Hospital
Phase 3 Completed
NCT04157985 2025-12-11
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
Phase 3 Completed
NCT03013010 2025-12-08
PREACT
Shanghai Cancer Hospital, China
Phase 3 Completed
NCT03813784 2025-09-16
A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic Therapy
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Completed
NCT02872116 2025-08-07
CheckMate649
Bristol-Myers Squibb
Phase 3 Completed
NCT01815853 2025-07-03
Neo-CRAG
Sun Yat-sen University
Phase 3 Completed
NCT02349412 2025-02-07
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT02578368 2024-11-12
FLOT5
Krankenhaus Nordwest
Phase 3 Completed
NCT02500043 2024-09-03
Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer
Taiho Oncology, Inc.
Phase 3 Completed
NCT03006705 2024-05-03
Study of Adjuvant ONO-4538 With Resected Gastric Cancer
Ono Pharmaceutical Co. Ltd
Phase 3 Completed
NCT01515748 2023-12-13
PRODIGY
Sanofi
Phase 3 Completed
NCT02178956 2023-11-15
BRIGHTER
Sumitomo Pharma America, Inc.
Phase 3 Completed
NCT02853474 2023-04-26
EPIC-1511
Centre Oscar Lambret
Phase 3 Completed
NCT02494583 2023-04-13
MK-3475-062
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT03745170 2023-03-01
Efficacy and Safety Evaluation of Sintilimab or Placebo in Combination With XELOX as First Line Treatment in Patients With Gastric Cancer
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3 Completed
NCT02370498 2022-06-06
MK-3475-061
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT02322593 2021-12-20
SOLAR
Taiho Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT02395640 2021-10-26
The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancer
Fudan University
Phase 3 Completed
NCT02158988 2021-07-29
GASTRIPEC
Charite University, Berlin, Germany
Phase 3 Completed
NCT03196791 2021-07-12
Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient
Korea University Anam Hospital
Phase 3 Completed
NCT00002883 2021-02-23
Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus
UNICANCER
Phase 3 Completed
NCT02625623 2020-11-24
Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)
EMD Serono
Phase 3 Completed
NCT02114359 2020-10-23
Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer
Seoul National University Hospital
Phase 3 Completed
NCT02545504 2020-05-26
GAMMA-1
Gilead Sciences
Phase 3 Completed
NCT00052910 2020-05-07
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00016380 2020-04-03
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen
Canadian Cancer Trials Group
Phase 3 Completed
NCT01248403 2020-01-29
AIO-STO-0111
Krankenhaus Nordwest
Phase 3 Completed
NCT00296322 2020-01-18
Trial of Adjuvant Chemotherapy for Gastric Cancer
Asan Medical Center
Phase 3 Completed
NCT00917384 2019-09-25
Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma
Eli Lilly and Company
Phase 3 Completed
NCT01170663 2019-09-18
RAINBOW
Eli Lilly and Company
Phase 3 Completed
NCT02647476 2019-02-27
Postoperative Enteral Immunonutrition in Gastric Cancer
Jagiellonian University
Phase 3 Completed
NCT02490111 2019-02-08
Clinical Trials for the Prevention of Gallstone Formation After Gastrectomy in Patient With Gastric Cancer
Daewoong Pharmaceutical Co. LTD.
Phase 3 Completed
NCT01824459 2019-01-23
S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients
Sun Yat-sen University
Phase 3 Completed
NCT02120885 2019-01-22
Gastric cancer
Yonsei University
Phase 3 Completed
NCT01065688 2018-10-09
A Trial of Reconstruction After Distal Gastrectomy for Gastric Cancer
Wakayama Medical University
Phase 3 Completed
NCT02706184 2018-05-15
EcNO
University of Hohenheim
Phase 3 Completed
NCT00887822 2017-03-01
AVATAR
Hoffmann-La Roche
Phase 3 Completed
NCT01099085 2017-02-17
Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer Patients
Samsung Medical Center
Phase 3 Completed
NCT02988635 2016-12-09
Early Palliative Care on Quality of Life of Advanced Cancer Patients
Azienda Ospedaliero-Universitaria di Parma
Phase 3 Completed
NCT01662869 2016-11-02
A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer
Hoffmann-La Roche
Phase 3 Completed
NCT02560974 2016-11-02
A Study of Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric Cancer
Hoffmann-La Roche
Phase 3 Completed
NCT02563054 2016-11-02
A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer
Hoffmann-La Roche
Phase 3 Completed
NCT01512745 2016-10-17
Phase III Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Completed
NCT00112099 2016-09-22
GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110
Japan Clinical Oncology Group
Phase 3 Completed
NCT00147147 2016-09-22
Randomized Trial of Adjuvant Chemotherapy With Cisplatin Followed by UFT in Serosa-positive Gastric Cancer (JCOG9206-2)
Japan Clinical Oncology Group
Phase 3 Completed
NCT00149279 2016-09-22
A Trial to Evaluate Para-aortic Lymphadenectomy for Gastric Cancer
Japan Clinical Oncology Group
Phase 3 Completed
NCT00252161 2016-09-22
A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer
Japan Clinical Oncology Group
Phase 3 Completed
NCT00142350 2016-09-12
A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer
Japan Clinical Oncology Group
Phase 3 Completed
NCT00216034 2016-06-07
Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK
Hokuriku-Kinki Immunochemotherapy Study Group
Phase 3 Completed